These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1832718)

  • 61. Molecular and functional studies of tyrosinase variants among Indian oculocutaneous albinism type 1 patients.
    Chaki M; Sengupta M; Mondal M; Bhattacharya A; Mallick S; Bhadra R; ; Ray K
    J Invest Dermatol; 2011 Jan; 131(1):260-2. PubMed ID: 20861851
    [No Abstract]   [Full Text] [Related]  

  • 62. Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).
    Ghodsinejad Kalahroudi V; Kamalidehghan B; Arasteh Kani A; Aryani O; Tondar M; Ahmadipour F; Chung LY; Houshmand M
    PLoS One; 2014; 9(9):e106656. PubMed ID: 25216246
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Variation in the tyrosinase gene associated with a white humpback whale (Megaptera novaeangliae).
    Polanowski AM; Robinson-Laverick SM; Paton D; Jarman SN
    J Hered; 2012; 103(1):130-3. PubMed ID: 22140253
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
    Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
    J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Temperature sensitive oculocutaneous albinism associated with missense changes in the tyrosinase gene.
    Wang T; Waters CT; Jakins T; Yates JR; Trump D; Bradshaw K; Moore AT
    Br J Ophthalmol; 2005 Oct; 89(10):1383-4. PubMed ID: 16170149
    [No Abstract]   [Full Text] [Related]  

  • 66. Novel human pathological mutations. Gene symbol: TYR. Disease: Albinism, oculocutaneous 1.
    Saxena R; Verma IC
    Hum Genet; 2010 Apr; 127(4):488. PubMed ID: 21491619
    [No Abstract]   [Full Text] [Related]  

  • 67. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene.
    Shimizu H; Niizeki H; Suzumori K; Aozaki R; Kawaguchi R; Hikiji K; Nishikawa T
    J Invest Dermatol; 1994 Jul; 103(1):104-6. PubMed ID: 8027570
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular genetics of oculocutaneous albinism.
    Spritz RA
    Hum Mol Genet; 1994; 3 Spec No():1469-75. PubMed ID: 7849740
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
    Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
    J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population.
    Passmore LA; Kaesmann-Kellner B; Weber BH
    Hum Genet; 1999 Sep; 105(3):200-10. PubMed ID: 10987646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ocular findings in patients with oculocutaneous albinism type ia with G47D tyrosinase gene mutation in Puerto Rico: a case report.
    Rodríguez-Agramonte F; Izquierdo NJ; Cadilla C
    Bol Asoc Med P R; 2013; 105(2):62-4. PubMed ID: 23882993
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.
    Tanita M; Matsunaga J; Miyamura Y; Dakeishi M; Nakamura E; Kono M; Shimizu H; Tagami H; Tomita Y
    J Hum Genet; 2002; 47(1):1-6. PubMed ID: 11829136
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Misrouting of tyrosinase with a truncated cytoplasmic tail as a result of the murine platinum (cp) mutation.
    Beermann F; Orlow SJ; Boissy RE; Schmidt A; Boissy YL; Lamoreux ML
    Exp Eye Res; 1995 Nov; 61(5):599-607. PubMed ID: 8654502
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene.
    Lin YY; Wei AH; He X; Zhou ZY; Lian S; Zhu W
    Eur J Dermatol; 2014; 24(2):168-73. PubMed ID: 24721949
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gene symbol: TYR. Disease: Albinism, oculocutaneous 1.
    Ray K; Chaki M; Mukhopadhyay A
    Hum Genet; 2005 Jul; 117(2-3):299. PubMed ID: 16156027
    [No Abstract]   [Full Text] [Related]  

  • 76. The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2).
    Manga P; Orlow SJ
    J Dermatol; 1999 Nov; 26(11):738-47. PubMed ID: 10635616
    [No Abstract]   [Full Text] [Related]  

  • 77. Leucodystrophy and oculocutaneous albinism in a child with an 11q14 deletion.
    Coupry I; Taine L; Goizet C; Soriano C; Mortemousque B; Arveiler B; Lacombe D
    J Med Genet; 2001 Jan; 38(1):35-8. PubMed ID: 11134238
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Five novel mutations in tyrosinase gene of Japanese and Indian patients with oculocutaneous albinism type I (OCA1).
    Miyamura Y; Verma IC; Saxena R; Hoshi M; Murase A; Nakamura E; Kono M; Suzuki T; Yasue S; Shibata S; Sakakibara A; Tomita Y
    J Invest Dermatol; 2005 Aug; 125(2):397-8. PubMed ID: 16098056
    [No Abstract]   [Full Text] [Related]  

  • 79. Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.
    Gershoni-Baruch R; Rosenmann A; Droetto S; Holmes S; Tripathi RK; Spritz RA
    Am J Hum Genet; 1994 Apr; 54(4):586-94. PubMed ID: 8128955
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
    Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.